Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-7-12
pubmed:abstractText
Stress has been associated with the onset of schizophrenia and exacerbation of psychotic symptoms. Patients with schizotypal personality disorder (SPD), the prototypic schizophrenia spectrum disorder, do not develop the frank psychosis of schizophrenia and appear clinically to be less reactive to stress than schizophrenic patients. Schizophrenic patients demonstrate increased dopaminergic (DA) and hypothalamic-pituitary-adrenal-axis (HPA) activation following 2-deoxyglucose (2-DG), an acute metabolic (glycopyruvic) stressor, compared to healthy volunteers (HV). We hypothesized that SPD patients would demonstrate comparable or lower DA and HPA responses after 2-DG to HV.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0920-9964
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27-31
pubmed:dateRevised
2010-9-2
pubmed:meshHeading
pubmed-meshheading:15246460-Acute Disease, pubmed-meshheading:15246460-Adult, pubmed-meshheading:15246460-Antimetabolites, pubmed-meshheading:15246460-Deoxyglucose, pubmed-meshheading:15246460-Dopamine, pubmed-meshheading:15246460-Double-Blind Method, pubmed-meshheading:15246460-Drug Administration Schedule, pubmed-meshheading:15246460-Female, pubmed-meshheading:15246460-Glucose, pubmed-meshheading:15246460-Homovanillic Acid, pubmed-meshheading:15246460-Humans, pubmed-meshheading:15246460-Hydrocortisone, pubmed-meshheading:15246460-Hypothalamo-Hypophyseal System, pubmed-meshheading:15246460-Infusions, Intravenous, pubmed-meshheading:15246460-Male, pubmed-meshheading:15246460-Pituitary-Adrenal System, pubmed-meshheading:15246460-Pyruvic Acid, pubmed-meshheading:15246460-Schizotypal Personality Disorder
pubmed:year
2004
pubmed:articleTitle
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder.
pubmed:affiliation
Department of Psychiatry, Mt. Sinai School of Medicine Clinical Reseach Center, New York, NY 10029, USA. vivian.mitropoulou@mssm.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial